Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rapid clinical and transcriptomic response to anifrolumab in refractory anti-TIF1γ–positive juvenile dermatomyositis

11 Apr 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Eosinophilic Disorders and Syndromes
Share to Inflammatory Myopathies and Dermatomyositis
Share to Muscle Physiology and Disorders

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40221262
DOI: 10.1016/j.ard.2025.02.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rapid clinical and transcriptomic response to anifrolumab in refractory anti-TIF1γ–positive juvenile dermatomyositisPMID 40221262Read ↗

Profile of patients with Juvenile Dermatomyositis and Anti-MDA5 autoantibodiesSemantic proximity Read ↗

Comprehensive analysis reveals potential molecular targets in Juvenile DermatomyositisSemantic proximity Read ↗

TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen PlanopilarisSemantic proximity Read ↗

Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseasesSemantic proximity Read ↗

Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactiveSemantic proximity Read ↗

Current evidence for janus kinase inhibitors in adult and juvenile dermatomyositis and key comparisonsSemantic proximity Read ↗

PReS-FINAL-2130: Antibodies to MDA5 correlate with a distinct phenotype in children with juvenile dermatomyositis, including higher risk of lung involvement and ulcerative skin diseaseSemantic proximity Read ↗

Tralokinumab shows clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis: A multicenter, prospective, open-label case series study.Semantic proximity Read ↗

Targeting IRF4 in autoimmune diseasesSemantic proximity Read ↗

MDA5+ Dermatomyositis Is Associated with Stronger Skin Type I Interferon Transcriptomic Signature with Upregulation of IFN-κ TranscriptSemantic proximity Read ↗

NanoString technology distinguishes anti-TIF-1γ+ from anti-Mi-2+ dermatomyositis patients.Semantic proximity Read ↗

Clinical and Molecular Effects of TYK2/JAK1 Inhibition in DermatomyositisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.